Evidence map›Paper›PMID 42042073›Full record

ArticleCurrent issues in molecular biology2026

Curcumin Attenuates LPS-Induced Migration/EMT and LPS/ATP-Associated IL-1β Release in Androgen-Independent Prostate Cancer Cells.

Mon-Der Cho, Shang-Yu Chou, Yu-Ming Hsu, Chi-Ying Li, Yi-Hong Tsai, Fang-Rong Chang

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mon-Der ChoGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.ORCID 0000-0002-0671-7614
Shang-Yu ChouDepartment of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 824005, Taiwan.
Yu-Ming HsuDepartment of Pharmacy and Master Program, College of Pharmacy and Health Care, Tajen University, Pingtung County 907101, Taiwan.ORCID 0000-0002-0958-3025
Chi-Ying LiSchool of Pharmacy, Tzu Chi University, Hualien 970374, Taiwan.
Yi-Hong TsaiDepartment of Pharmacy and Master Program, College of Pharmacy and Health Care, Tajen University, Pingtung County 907101, Taiwan.ORCID 0000-0003-4674-3363
Fang-Rong ChangGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.ORCID 0000-0003-2549-4193

Funding

Kaohsiung Municipal Min-Sheng Hospital KMSH-11303
6 · The paper itself

Abstract

Inflammation can promote aggressive phenotypes in prostate cancer, including enhanced migration/EMT-like changes and inflammasome-associated cytokine release. Here, we examined whether curcumin modulates these inflammation-driven responses in androgen-independent prostate cancer cells. PC-3 and DU145 cells were treated with curcumin (10 or 25 μM) or N-acetylcysteine (NAC; 2 mM). Sub-cytotoxic dosing was defined by CCK-8 viability assays. LPS (0.5 μg/mL) was used to induce motility-, invasion-, and EMT-associated responses, assessed by wound-healing assay, Matrigel-coated Transwell invasion assay, and RT-qPCR of

Indexed as

curcuminepithelial–mesenchymal transition (EMT)lipopolysaccharide (LPS)NLRP3 inflammasomeprostate cancerreactive oxygen species (ROS)

Identifiers

PMID42042073
PMCPMC13114565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.